Yes, records of batch release decisions are examined during drug quality audits in Japan. These audits ensure compliance with Good Manufacturing Practices (GMP) and verify that each batch meets quality standards before market release. Inspectors review documentation to confirm that all necessary tests and approvals have been properly conducted and recorded.
